Browse

A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies

Cited 14 time in Web of Science Cited 14 time in Scopus
Authors
Oh, Jee-Young; Lim, Soo; Kim, Dae Jung; Kim, Nan Hee; Kim, Dong Jun; Moon, Sung Dae; Jang, Hak Chul; Cho, Young Min; Song, Kee-Ho; Ahn, Chul Woo; Sung, Yeon-Ah; Park, Joong-Yeol; Shin, Chol; Lee, Hong Kyu; Park, Kyong Soo
Issue Date
2008-03-15
Publisher
Elsevier
Citation
Diabetes Res Clin Pract. 80 (2008) 463-468
Keywords
AdultAgedBlood Glucose/metabolismBlood PressureBody Mass IndexCohort StudiesFemaleHumansHyperglycemia/classification/*diagnosis/*epidemiologyKorea/epidemiologyMaleMiddle AgedWaist-Hip Ratio
Abstract
Many studies show poor agreement between fasting plasma glucose (FPG)-based and 2-h postchallenge glucose (2-h PG)-based criteria to assess glucose metabolism. We examined the rate of agreement between FPG- and 2-h PG-based criteria in the diagnosis of intermediate hyperglycemia in four representative cohort studies in South Korea and compared the clinical characteristics and biochemical parameters in subjects with impaired fasting glucose (IFG) according to their FPG values. Of 6234 subjects from four population-based studies performed from 1993 to 2000, 4610 individuals with data from a 75g oral glucose tolerance test (OGTT) and no previous history of diabetes were selected. We examined the concordance rate between the FPG and 2-h PG-based criteria. We also investigated the differences in the clinical characteristics and biochemical parameters between individuals with IFG according to their FPG values. The fasting and 2-h PG criteria had large discordance rates in the diagnosis of diabetes and impaired glucose tolerance (IGT) in Korean adults. When individuals with IFG were classified into stage 1 [5.6-6.1mmol/L (100-109mg/dL)] and stage 2 [6.1-7.0mmol/L (110-125mg/dL)] IFG, individuals with stage 2 IFG are more obese and had higher blood pressure and total cholesterol and triglycerides concentrations compared with those with stage 1 IFG. In addition, more individuals with stage 2 IFG were with diabetes as determined by a 2-h PG>or=11.1mmol/L (14.1% vs. 1.9%) (P<0.05). Considering the poorer metabolic profile and higher percentage of people with diabetes by OGTT, these data indicate that, in the Korean population, individuals with stage 2 IFG should be treated differently from those with stage 1 IFG. To detect more cases of diabetes, the OGTT is recommended for all individuals with stage 2 IFG and cases with stage 1 IFG with some additional risk factors for diabetes.
ISSN
1872-8227 (Electronic)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18339440

http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T5Y-4S1SJGK-2-1&_cdi=5015&_user=168665&_orig=search&_coverDate=06%2F30%2F2008&_sk=999199996&view=c&wchp=dGLbVzb-zSkzV&md5=9e8714fdfdeb20349e6f3023c5775684&ie=/sdarticle.pdf

https://hdl.handle.net/10371/67872
DOI
https://doi.org/10.1016/j.diabres.2008.01.022
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse